Filing Details
- Accession Number:
- 0001225208-18-012323
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-08-06 15:19:23
- Reporting Period:
- 2018-08-03
- Accepted Time:
- 2018-08-06 15:19:23
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
78003 | Pfizer Inc | PFE | Pharmaceutical Preparations (2834) | 135315170 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1678459 | R Alexander Mackenzie | Pfizer Inc.-Corp. Secretary 235 East 42Nd St. New York NY 10017 | Executive Vice President | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2018-08-03 | 100 | $39.56 | 127,954 | No | 4 | S | Direct | |
Common Stock | Disposition | 2018-08-03 | 100 | $39.52 | 127,854 | No | 4 | S | Direct | |
Common Stock | Disposition | 2018-08-03 | 2,100 | $39.55 | 125,754 | No | 4 | S | Direct | |
Common Stock | Disposition | 2018-08-03 | 4,500 | $39.53 | 121,254 | No | 4 | S | Direct | |
Common Stock | Disposition | 2018-08-03 | 6,400 | $39.51 | 114,854 | No | 4 | S | Direct | |
Common Stock | Disposition | 2018-08-03 | 12,442 | $39.50 | 102,412 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 9,120 | Indirect | By Rule 16b-3 Plan |